Interview with Alina Culcea, Managing Director, Actavis Romania
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
Address: Actavis Romania, Ion Mihalache Blvd. 11, sector 1, Bucharest 011 171, Romania
Tel: +40 21 351 45 67
Web: http://www.actavis.com.ro/ro/default.htm
Having joined Actavis Group in March 2006, the Romanian division strengthens the group’s oncology actavities. The Romanian branch embraces the Group’s center of excellence for the development, production and marketing of generic oncology medicines.
With a broad portfolio of oncology products, the company has a successful presence in a growing number of foreign markets. The latest market within the portfolio are in the United States and Japan, where since 2008, the company sells oncology products manufactured in the production unit in Bucharest – Sindan Pharma, a company previously acquired by Actavis Group in 2006.
Actavis offers its customers the broadest product portfolio and the most advanced production line of generic drugs. Currently, Actavis sells over 830 products (over 10,000 SKUs) in hospitals and pharmacies around the world, covering all relevant therapeutic areas. In 2008, the Company has launched over 660 products (235 molecules) and for 2009 it is expected that number to rise to 800 launches of new products.
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
APMGR is obviously a rather young association that has only really been active since about a year now. Can you first comment on the timing that the Association was called…
Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over these five decades, thorough…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones…
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract foreign investors. In sum,…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market environment was at that…
You have been the first employee to start Dr. Reddy’s in Romania and when we look back at those early years, we see that a portfolio of gastroenterology and analgesics…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on…
While, today, you are in charge of voicing the concerns of the innovators in the country, let us first take a step back and see what attracted these companies to…
In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all elaborate on the key…
Increasing integration with the world economy and accession to the European Union (EU) in 2007 have been key pillars in taking the growth potential of Romania’s pharmaceutical market to greater…
You have been general manager of this affiliate for three years after a previous tenure as general manager of Leo Pharma here and in Bulgaria. The end of 2008 through…
We understand that you have been heading IMS Health in Romania for 10 years now, which has been quite a trajectory. Therefore, can you highlight the key milestones and achievements…
See our Cookie Privacy Policy Here
